Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple Sclerosis
Figure 1
(a) Time course of left ventricular ejection fraction (EF%) during mitoxantrone treatment of 19 patients. In several patients, time on treatment was prolonged due to temporary interruptions of treatment. The time course of individual patients is denoted by the same letter throughout Figures 1(a) and 1(b). (b) Time course of left ventricular ejection fraction (EF%) after the end of mitoxantrone treatment in the same 19 patients is shown in Figure 1(a).
